{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:59:40Z","timestamp":1761541180283},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2013,10,28]],"date-time":"2013-10-28T00:00:00Z","timestamp":1382918400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0077825","type":"journal-article","created":{"date-parts":[[2013,10,28]],"date-time":"2013-10-28T20:59:05Z","timestamp":1382993945000},"page":"e77825","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Variation in Cell Signaling Protein Expression May Introduce Sampling Bias in Primary Epithelial Ovarian Cancer"],"prefix":"10.1371","volume":"8","author":[{"given":"Gabriele","family":"Mittermeyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Malinowsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Beese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz","family":"H\u00f6fler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Schmalfeldt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl-Friedrich","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Avril","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,10,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics, 2012","volume":"62","author":"R Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"ref2","first-page":"S161","article-title":"Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer","volume":"95","author":"AP Heintz","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMra041842","article-title":"Cancer of the ovary","volume":"351","author":"SA Cannistra","year":"2004","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/bjc.2012.541","article-title":"Targeted anti-vascular therapies for ovarian cancer: current evidence","volume":"108","author":"M Hall","year":"2013","journal-title":"Br J Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1200\/JCO.2007.11.5345","article-title":"Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study","volume":"25","author":"RA Burger","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"5180","DOI":"10.1200\/JCO.2007.12.0782","article-title":"Phase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancer","volume":"25","author":"SA Cannistra","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/ijc.20751","article-title":"Inhibition of peritoneal dissemination of ovarian cancer by tyrosine kinase receptor inhibitor SU6668 (TSU-68)","volume":"114","author":"S Machida","year":"2005","journal-title":"Int J Cancer"},{"key":"ref8","first-page":"445","article-title":"Inhibition of malignant ascites and growth of human ovarian carcinoma by oral administration of a potent inhibitor of the vascular endothelial growth factor receptor tyrosine kinases","volume":"16","author":"L Xu","year":"2000","journal-title":"Int J Oncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ygyno.2004.11.051","article-title":"Activation of PI3K\/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line","volume":"97","author":"S Lee","year":"2005","journal-title":"Gynecol Oncol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.bbrc.2010.03.029","article-title":"Role of the Akt\/mTOR survival pathway in cisplatin resistance in ovarian cancer cells","volume":"394","author":"DJ Peng","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1158\/0008-5472.CAN-05-0425","article-title":"Akt-mediated cisplatin resistance in ovarian cancer: modulation of p53 action on caspase-dependent mitochondrial death pathway","volume":"66","author":"X Yang","year":"2006","journal-title":"Cancer Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1155\/2010\/126295","article-title":"Precursor lesions of high-grade serous ovarian carcinoma: morphological and molecular characteristics","volume":"2010","author":"AL Gross","year":"2010","journal-title":"J Oncol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.molonc.2009.01.004","article-title":"Intercepting pelvic cancer in the distal fallopian tube: theories and realities","volume":"3","author":"CP Crum","year":"2009","journal-title":"Mol Oncol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1002\/pmic.200300598","article-title":"Signal pathway profiling of prostate cancer using reverse phase protein arrays","volume":"3","author":"RL Grubb","year":"2003","journal-title":"Proteomics"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1038\/sj.onc.1204265","article-title":"Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front","volume":"20","author":"CP Paweletz","year":"2001","journal-title":"Oncogene"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/pmic.200300592","article-title":"Protein microarrays: molecular profiling technologies for clinical specimens","volume":"3","author":"V Espina","year":"2003","journal-title":"Proteomics"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1535-6108(03)00086-2","article-title":"Protein microarrays: meeting analytical challenges for clinical applications","volume":"3","author":"LA Liotta","year":"2003","journal-title":"Cancer Cell"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/ncponc0485","article-title":"Technology insight: pharmacoproteomics for cancer\u2013promises of patient-tailored medicine using protein microarrays","volume":"3","author":"JD Wulfkuhle","year":"2006","journal-title":"Nat Clin Pract Oncol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-1-61779-286-1_8","article-title":"Use of formalin-fixed and paraffin-embedded tissues for diagnosis and therapy in routine clinical settings","volume":"785","author":"D Berg","year":"2011","journal-title":"Methods Mol Biol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1477-5956-10-56","article-title":"An efficient procedure for protein extraction from formalin-fixed, paraffin-embedded tissues for reverse phase protein arrays","volume":"10","author":"H Guo","year":"2012","journal-title":"Proteome Sci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/path.2791","article-title":"Signalling networks associated with urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in breast cancer tissues: new insights from protein microarray analysis","volume":"223","author":"C Wolff","year":"2011","journal-title":"J Pathol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"6426","DOI":"10.1158\/1078-0432.CCR-12-0452","article-title":"Molecular analysis of HER2 signaling in human breast cancer by functional protein pathway activation mapping","volume":"18","author":"JD Wulfkuhle","year":"2012","journal-title":"Clin Cancer Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e40285","DOI":"10.1371\/journal.pone.0040285","article-title":"Common protein biomarkers assessed by reverse phase protein arrays show considerable intratumoral heterogeneity in breast cancer tissues","volume":"7","author":"K Malinowsky","year":"2012","journal-title":"PLoS One"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e16353","DOI":"10.1371\/journal.pone.0016353","article-title":"Successful protein extraction from over-fixed and long-term stored formalin-fixed tissues","volume":"6","author":"C Wolff","year":"2011","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-1-61779-286-1_9","article-title":"Producing reverse phase protein microarrays from formalin-fixed tissues","volume":"785","author":"C Wolff","year":"2011","journal-title":"Methods Mol Biol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/BF01774016","article-title":"Accurate assessment of precision errors: how to measure the reproducibility of bone densitometry techniques","volume":"5","author":"CC Gluer","year":"1995","journal-title":"Osteoporos Int"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"14863","DOI":"10.1073\/pnas.95.25.14863","article-title":"Cluster analysis and display of genome-wide expression patterns","volume":"95","author":"MB Eisen","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory","volume":"34","author":"RJ Kurman","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/stem.1029","article-title":"Intratumoral heterogeneity in the self-renewal and tumorigenic differentiation of ovarian cancer","volume":"30","author":"S Abelson","year":"2012","journal-title":"Stem Cells"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/(SICI)1097-0215(19990909)82:6<822::AID-IJC9>3.0.CO;2-I","article-title":"Somatic genetic alterations (LOH) in benign, borderline and invasive ovarian tumours: intratumoral molecular heterogeneity","volume":"82","author":"I Zborovskaya","year":"1999","journal-title":"Int J Cancer"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1113205","article-title":"Intratumor heterogeneity and branched evolution revealed by multiregion sequencing","volume":"366","author":"M Gerlinger","year":"2012","journal-title":"N Engl J Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/(SICI)1522-2683(19990101)20:4\/5<1039::AID-ELPS1039>3.0.CO;2-4","article-title":"Two-dimensional gel analysis of protein expression in ovarian tumors shows a low degree of intratumoral heterogeneity","volume":"20","author":"AA Alaiya","year":"1999","journal-title":"Electrophoresis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0002-9378(11)80020-7","article-title":"Analysis of antigen expression at multiple tumor sites in epithelial ovarian cancer","volume":"164","author":"SC Rubin","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/PGP.0b013e31820d20ba","article-title":"Biomarker expression in pelvic high-grade serous carcinoma: comparison of ovarian and omental sites","volume":"30","author":"M Kobel","year":"2011","journal-title":"Int J Gynecol Pathol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0077825","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T13:08:45Z","timestamp":1540300125000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0077825"}},"subtitle":[],"editor":[{"given":"Ruby John","family":"Anto","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,10,28]]},"references-count":34,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2013,10,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0077825","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,28]]}}}